Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmenopausal oestrogens and arteries

S Vyas1, K Gangar

  • 1Southmead Hospital, Westbury-on-Trym, Bristol.

British Journal of Obstetrics and Gynaecology
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The management of women with thoracic endometriosis: a national survey of British gynaecological endoscopists.

Facts, views & vision in ObGyn·2021
Same author

Cognitive Performance and Neuro-Metabolites in HIV Using 3T Magnetic Resonance Spectroscopy: A Cross-Sectional Study from India.

Current HIV research·2020
Same author

Identification of differentially expressed genes profiles in a combined mouse model of Parkinsonism and colitis.

Scientific reports·2020
Same author

An epidemiological evaluation of predictors of overweight and obesity in Garhwal region of Uttarakhand.

Journal of preventive medicine and hygiene·2019
Same author

Papilloedema: diffusion-weighted imaging of optic nerve head.

Clinical radiology·2019
Same author

'Cerebral Cysticercosis' in the era of magnets: do we still need to punch the brain first?

QJM : monthly journal of the Association of Physicians·2018
Same journal

Livial: an economic appraisal.

British journal of obstetrics and gynaecology·2000
Same journal

Livial: a review of clinical studies.

British journal of obstetrics and gynaecology·2000
Same journal

Place of birth and shoulder dystocia.

British journal of obstetrics and gynaecology·1999
Same journal

The value of the negative predictive values.

British journal of obstetrics and gynaecology·1999
Same journal

Splenectomy during pregnancy: an option in treatment of autoimmune thrombocytopenic purpura.

British journal of obstetrics and gynaecology·1999
Same journal

Third trimester abortion: is compassion enough?

British journal of obstetrics and gynaecology·1999
See all related articles

Postmenopausal estrogen therapy significantly reduces cardiovascular risks and bone loss, offering substantial health benefits for women. Routine HRT is recommended, especially for those without a uterus, pending further research on combined therapies.

Area of Science:

  • Reproductive Endocrinology
  • Cardiovascular Health
  • Gerontology

Background:

  • Postmenopausal estrogen therapy is linked to reduced cardiovascular morbidity and mortality.
  • Epidemiological data suggest compelling evidence, supported by biologically plausible mechanisms.
  • Hormone replacement therapy (HRT) also alleviates climacteric symptoms and preserves bone density.

Purpose of the Study:

  • To evaluate the benefits and risks of postmenopausal estrogen therapy.
  • To assess the routine offering of unopposed estrogen for postmenopausal women post-hysterectomy.
  • To address the urgent need for data on cardiovascular protection with opposed HRT.

Main Methods:

  • Review of epidemiological data and biologically plausible mechanisms.

Related Experiment Videos

  • Consideration of consensus conference findings (Lobo & Speroff 1994).
  • Analysis of benefits versus potential risks for different groups of women.

    • Main Results:

    • Unopposed estrogen therapy is recommended routinely for postmenopausal women without a uterus.
    • Women with a uterus require estrogen with cyclical progestogens; cardiovascular effects need urgent study.
    • Estrogen's role in primary cardiovascular disease prevention is considered to outweigh potential risks for most women.

    Conclusions:

    • Postmenopausal estrogen therapy offers significant cardiovascular and bone health benefits.
    • Routine HRT should be considered for postmenopausal women, with specific recommendations based on uterine status.
    • Further research is crucial to clarify risks and benefits of opposed HRT for cardiovascular protection.